Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 51991-981

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 51991-981). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zolpidem 01)

Chemical Structure (Zolpidem 01)
Chemical structure illustration of the active ingredient Zolpidem Tartrate, showing the molecular components and arrangement including two main structural groups.*
FDA Label Image

Figure 1 (Zolpidem 02)

Figure 1 (Zolpidem 02)
A line graph comparing zolpidem plasma concentrations (ng/mL) over time (hours) for 12.5 mg zolpidem tartrate extended-release tablets versus 10 mg zolpidem tartrate immediate-release tablets. The graph shows concentration curves from 0 to 8 hours, illustrating different release profiles between extended and immediate release forms.*
FDA Label Image

Principal Display Panel (6.25 mg Tablet Bottle Label)

Principal Display Panel (6.25 mg Tablet Bottle Label)
Label for Zolpidem Tartrate extended-release tablets, USP, showing the 6.25 mg strength. The label includes storage instructions, directions to dispense in a child-resistant container, distributor Breckenridge Pharmaceutical, Inc., and indicates the package contains 100 tablets. The manufacturer is Centaur Pharmaceuticals Pvt. Ltd., India.*
FDA Label Image

Principal Display Panel (12.5 mg Tablet Bottle Label)

Principal Display Panel (12.5 mg Tablet Bottle Label)
Zolpidem Tartrate 12.5 mg extended-release tablets label. The label includes dosage form as tablets for oral use, packaging of 100 tablets, and the distributor Breckenridge Pharmaceutical, Inc. It also mentions manufacturing by Centaur Pharmaceuticals Pvt. Ltd., India, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.